Pregnancy and renal outcomes in lupus nephritis: An update and guide to management

Lupus

Volumn 21, Issue 12, 2012, Pages 1271-1283

  Bramham, K ^b,c   Soh, M C ^b,c   Nelson Piercy, C ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Pregnancy; Renal Lupus; Systemic Lupus Erythematosus

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GONADORELIN ANTAGONIST; HYDROXYCHLOROQUINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHOLIPID ANTIBODY; TACROLIMUS;

ADVERSE OUTCOME; CHRONIC KIDNEY DISEASE; CLEFT LIP; CLEFT PALATE; CONGENITAL HEART BLOCK; CORTICOSTEROID THERAPY; CUTANEOUS NEONATAL LUPUS; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE FERTILITY; FETUS WASTAGE; FIRST TRIMESTER PREGNANCY; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; MAINTENANCE THERAPY; MATERNAL MORTALITY; META ANALYSIS (TOPIC); NEWBORN DISEASE; OVARY FUNCTION; PATIENT COUNSELING; PATIENT MONITORING; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; PUERPERIUM; REMISSION; REVIEW; SKIN LUPUS ERYTHEMATOSUS; SMALL FOR DATE INFANT; THROMBOSIS PREVENTION;

ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; HYPERTENSION; KIDNEY FUNCTION TESTS; LUPUS NEPHRITIS; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL CARE; TIME FACTORS;

EID: 84866979598     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312456893     Document Type: Review

References (113)

1. Dooley M Lupus nephritis. Lewis E Schwartz M Korbet SM Tak Mao Chan D, ed. Oxford: Oxford University Press ; 2010: 1-34.
2. Venning M, Patel Mumtaz Renal disease in pregnancy. Davison JM Nelson-Piercy C Kehoe S Baker P, ed. London: RCOG Press ; 2008: 96-96.
3. Fraga A, Mintz G, Orozco J. Sterility and fertility rates, fetal wastage and maternal morbidity in systemic lupus erythematosus. J Rheumatol. 1974 ; 1: 193-198
4. Grigor RR, Shervington PC, Hughes GR, Hawkins DF. Outcome of pregnancy in systemic lupus erythematosus. Proc R Soc Med. 1977 ; 70: 99-100
5. Ramsey-Goldman R, Mientus JM, Kutzer JE, Mulvihill JJ, Medsger TA. Pregnancy outcome in women with systemic lupus erythematosus treated with immunosuppressive drugs. J Rheumatol. 1993 ; 20: 1152-1157
6. Hou S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am J Kidney Dis. 1999 ; 33: 235-252
7. Hou S. Pregnancy in renal transplant recipients. Adv Ren Replace Ther. 2003 ; 10: 40-47
8. McKay DB, Josephson MA. Pregnancy in recipients of solid organs-effects on mother and child. N Engl J Med. 2006 ; 354: 1281-1293
9. Warne GL, Fairley KF, Hobbs JB, Martin FI. Cyclophosphamide-induced ovarian failure. N Engl J Med. 1973 ; 289: 1159-1162
10. Park MC, Park YB, Jung SY, Chung IH, Choi KH, Lee SK. Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy. Lupus. 2004 ; 13: 569-574
11. Boumpas DT, Austin HA, Vaughan EM, Yarboro CH, Klippel JH, Balow JE. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med. 1993 ; 119: 366-369
12. Ioannidis JP, Katsifis GE, Tzioufas AG, Moutsopoulos HM. Predictors of sustained amenorrhea from pulsed intravenous cyclophosphamide in premenopausal women with systemic lupus erythematosus. J Rheumatol. 2002 ; 29: 2129-2135
13. Katsifis GE, Tzioufas AG. Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide. Lupus. 2004 ; 13: 673-678
14. Clowse ME, Behera MA, Anders CK, et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health (Larchmt). 2009 ; 18: 311-319
15. Chakravarty EF, Colon I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol. 2005 ; 192: 1897-1904
16. Cervera R, Font J, Carmona F, Balasch J. Pregnancy outcome in systemic lupus erythematosus: good news for the new millennium. Autoimmun Rev. 2002 ; 1: 354-359
17. Cortes-Hernandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology (Oxford). 2002 ; 41: 643-650
18. Ruiz-Irastorza G, Lima F, Alves J, et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol. 1996 ; 35: 133-138
19. Clowse ME, Magder LS, Witter F, Petri M. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005 ; 52: 514-521
20. Clowse ME, Jamison M, Myers E, James AH. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008 ; 199: 127 e1 - e6
21. Tandon A, Ibanez D, Gladman DD, Urowitz MB. The effect of pregnancy on lupus nephritis. Arthritis Rheum. 2004 ; 50: 3941-3946
22. Moroni G, Quaglini S, Banfi G, et al. Pregnancy in lupus nephritis. Am J Kidney Dis. 2002 ; 40: 713-720
23. Gladman DD, Tandon A, Ibanez D, Urowitz MB. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol. 2010 ; 37: 754-758
24. Petri M. Hopkins Lupus Pregnancy Center: 1987 to 1996. Rheum Dis Clin North Am. 1997 ; 23: 1-13
25. Zulman JI, Talal N, Hoffman GS, Epstein WV. Problems associated with the management of pregnancies in patients with systemic lupus erythematosus. J Rheumatol. 1980 ; 7: 37-49
26. Lockshin MD, Reinitz E, Druzin ML, Murrman M, Estes D. Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med. 1984 ; 77: 893-898
27. Meehan RT, Dorsey JK. Pregnancy among patients with systemic lupus erythematosus receiving immunosuppressive therapy. J Rheumatol. 1987 ; 14: 252-258
28. Petri M, Howard D, Repke J. Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum. 1991 ; 34: 1538-1545
29. Hayslett JP, Lynn RI. Effect of pregnancy in patients with lupus nephropathy. Kidney Int. 1980 ; 18: 207-220
30. Bobrie G, Liote F, Houillier P, Grunfeld JP, Jungers P. Pregnancy in lupus nephritis and related disorders. Am J Kidney Dis. 1987 ; 9: 339-343
31. Wong CH, Chen TL, Lee CS, Lin CJ, Chen CP. Outcome of pregnancy in patients with systemic lupus erythematosus. Taiwan J Obstet Gynecol. 2006 ; 45: 120-123
32. Imbasciati E, Surian M, Bottino S, et al. Lupus nephropathy and pregnancy. A study of 26 pregnancies in patients with systemic lupus erythematosus and nephritis. Nephron. 1984 ; 36: 46-51
33. Julkunen H, Kaaja R, Palosuo T, Gronhagen-Riska C, Teramo K. Pregnancy in lupus nephropathy. Acta Obstet Gynecol Scand. 1993 ; 72: 258-263
34. Fine LG, Barnett EV, Danovitch GM, Nissenson AR, Conolly MF, Lieb SM. Systemic lupus erythematosus during pregnancy. Ann Intern Med. 1981 ; 94: 667-677
35. Packham DK, Lam SS, Nicholls K, Fairley KF, Kincaid-Smith PS. Lupus nephritis and pregnancy. Q J Med. 1992 ; 83: 315-324
36. Bear R. Pregnancy and lupus nephritis. A detailed report of six cases with a review of the literature. Obstet Gynecol. 1976 ; 47: 715-718
37. Mintz G, Niz J, Gutierrez G, Garcia-Alonso A, Karchmer S. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol. 1986 ; 13: 732-739
38. McGee CD, Makowski EL. Systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol. 1970 ; 107: 1008-1012
39. Oviasu E, Hicks J, Cameron JS. The outcome of pregnancy in women with lupus nephritis. Lupus. 1991 ; 1: 19-25
40. Varner MW, Meehan RT, Syrop CH, Strottmann MP, Goplerud CP. Pregnancy in patients with systemic lupus erythematosus. Am J Obstet Gynecol. 1983 ; 145: 1025-1040
41. Houser MT, Fish AJ, Tagatz GE, Williams PP, Michael AF. Pregnancy and systemic lupus erythematosus. Am J Obstet Gynecol. 1980 ; 138: 409-413
42. Imbasciati E, Tincani A, Gregorini G, et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant. 2009 ; 24: 519-525
43. Smyth A, Oliveira GH, Lahr BD, Bailey KR, Norby SM, Garovic VD. A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 2010 ; 5: 2060-2068
44. Imbasciati E, Gregorini G, Cabiddu G, et al. Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes. Am J Kidney Dis. 2007 ; 49: 753-762
45. Tang H, Chelamcharla M, Baird BC, Shihab FS, Koford JK, Goldfarb-Rumyantzev AS. Factors affecting kidney-transplant outcome in recipients with lupus nephritis. Clin Transplant. 2008 ; 22: 263-272
46. McGrory CH, McCloskey LJ, DeHoratius RJ, Dunn SR, Moritz MJ, Armenti VT. Pregnancy outcomes in female renal recipients: a comparison of systemic lupus erythematosus with other diagnoses. Am J Transplant. 2003 ; 3: 35-42
47. Carmona F, Font J, Moga I, et al. Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases. Am J Reprod Immunol. 2005 ; 53: 182-188
48. Moroni G, Ponticelli C. Pregnancy after lupus nephritis. Lupus. 2005 ; 14: 89-94
49. Huong DL, Wechsler B, Vauthier-Brouzes D, Beaufils H, Lefebvre G, Piette JC. Pregnancy in past or present lupus nephritis: a study of 32 pregnancies from a single centre. Ann Rheum Dis. 2001 ; 60: 599-604
50. Wagner S, Craici I, Reed D, et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus. 2009 ; 18: 342-347
51. Bramham K, Hunt BJ, Bewley S, et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol. 2011 ; 38: 1906-1913
52. Ritchie J, Smyth A, Tower C, Helbert M, Venning M, Garovic V. Maternal deaths in women with lupus nephritis: a review of published evidence. Lupus. 2012 ; 21: 534-541
53. Rahman FZ, Rahman J, Al-Suleiman SA, Rahman MS. Pregnancy outcome in lupus nephropathy. Arch Gynecol Obstet. 2005 ; 271: 222-226
54. Soubassi L, Haidopoulos D, Sindos M, et al. Pregnancy outcome in women with pre-existing lupus nephritis. J Obstet Gynaecol. 2004 ; 24: 630-634
55. Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J. Lupus and pregnancy studies. Arthritis Rheum. 1993 ; 36: 1392-1397
56. Cavallasca JA, Laborde HA, Ruda-Vega H, Nasswetter GG. Maternal and fetal outcomes of 72 pregnancies in Argentine patients with systemic lupus erythematosus (SLE). Clin Rheumatol. 2008 ; 27: 41-46
57. Nelson-Piercy C Handbook of obstetric medicine. 4 th ed. London: InformaHealthcare; 2010, pp. 136-137. London: InformaHealthcare ; 2010: 136-137.
58. Cimaz R, Spence DL, Hornberger L, Silverman ED. Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr. 2003 ; 142: 678-683
59. Friedman DM, Rupel A, Buyon JP. Epidemiology, etiology, detection, and treatment of autoantibody-associated congenital heart block in neonatal lupus. Curr Rheumatol Rep. 2007 ; 9: 101-108
60. Pisoni CN, Brucato A, Ruffatti A, et al. Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study. Arthritis Rheum. 2010 ; 62: 1147-1152
61. Izmirly PM, Kim MY, Llanos C, et al. Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis. 2010 ; 69: 1827-1830
62. Jungers P, Dougados M, Pelissier C, et al. Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch Intern Med. 1982 ; 142: 771-776
63. Williams D, Davison J. Chronic kidney disease in pregnancy. BMJ. 2008 ; 336: 211-215
64. Stratta P, Canavese C, Quaglia M. Pregnancy in patients with kidney disease. J Nephrol. 2006 ; 19: 135-143
65. Sibai BM, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998 ; 339: 667-671
66. Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: a prospective study. Hypertension. 2008 ; 51: 1002-1009
67. Chakravarty EF, Nelson L, Krishnan E. Obstetric hospitalizations in the United States for women with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006 ; 54: 899-907
68. Lim W, Crowther MA, Eikelboom JW. Management of antiphospholipid antibody syndrome: a systematic review. JAMA. 2006 ; 295: 1050-1057
69. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
70. Nelson-Piercy C, Rosene-Montella K Medical care of the pregnant patient. 2 nd ed. Philadelphia: American College Physicians, 2008; pp. 513-521. Lee RV Rosene-Montella K Barbour LA Garner PR Keely E, ed. Philadelphia: American College Physicians ; 2008: 513-521.
71. Bramham K, Hunt BJ, Germain S, et al. Pregnancy outcome in different clinical phenotypes of antiphospholipid syndrome. Lupus. 2009 ; 19: 58-64
72. Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol. 2003 ; 101: 1333-1344
73. Soh M, Nelson-Piercy C. Antiphospholipid syndrome in pregnancy. Expert Reviews Obst Gyne. 2010 ; 5: 741-761
74. Cervera R, Tektonidou MG, Espinosa G, et al. Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations. Lupus. 2011 ; 20: 174-181
75. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998 ; 31: 1650-1657
76. Ostensen M, Khamashta M, Lockshin M, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006 ; 8: 209-209
77. Benediktsson R, Calder AA, Edwards CR, Seckl JR. Placental 11 beta-hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid exposure. Clin Endocrinol (Oxf). 1997 ; 46: 161-166
78. Park-Wyllie L, Mazzotta P, Pastuszak A, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000 ; 62: 385-392
79. Carmichael SL, Shaw GM, Ma C, Werler MM, Rasmussen SA, Lammer EJ. Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol. 2007 ; 197: 585.e1 - e7
80. Kallen B. Maternal drug use and infant cleft lip/palate with special reference to corticoids. Cleft Palate Craniofac J. 2003 ; 40: 624-628
81. Czeizel AE, Rockenbauer M. Population-based case-control study of teratogenic potential of corticosteroids. Teratology. 1997 ; 56: 335-340
82. Laskin CA, Bombardier C, Hannah ME, et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med. 1997 ; 337: 148-153
83. Moroni G, Ponticelli C. The risk of pregnancy in patients with lupus nephritis. J Nephrol. 2003 ; 16: 161-167
84. Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation. 2001 ; 71: 1051-1055
85. Armenti VT, Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Burke JF. National transplantation Pregnancy Registry-outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation. 1994 ; 57: 502-506
86. Kainz A, Harabacz I, Cowlrick IS, Gadgil SD, Hagiwara D. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation. 2000 ; 70: 1718-1721
87. Armenti VT, Radomski JS, Moritz MJ, et al. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2004 ;: 103-114
88. Francella A, Dyan A, Bodian C, Rubin P, Chapman M, Present DH. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterology. 2003 ; 124: 9-17
89. Moskovitz DN, Bodian C, Chapman ML, et al. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol. 2004 ; 99: 656-661
90. Sperber K, Hom C, Chao CP, Shapiro D, Ash J. Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatr Rheumatol Online J. 2009 ; 7: 9-9
91. Clowse ME, Magder L, Witter F, Petri M. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006 ; 54: 3640-3647
92. Le Ray C, Coulomb A, Elefant E, Frydman R, Audibert F. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations. Obstet Gynecol. 2004 ; 103: 1091-1094
93. Sifontis NM, Coscia LA, Constantinescu S, Lavelanet AF, Moritz MJ, Armenti VT. Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus. Transplantation. 2006 ; 82: 1698-1702
94. Kyle PM. Drugs and the fetus. Curr Opin Obstet Gynecol. 2006 ; 18: 93-99
95. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006 ; 354: 2443-2451
96. Khandelwal M, Kumanova M, Gaughan JP, Reece EA. Role of diltiazem in pregnant women with chronic renal disease. J Matern Fetal Neonatal Med. 2002 ; 12: 408-412
97. Esnault VL, Brown EA, Apetrei E, et al. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. Clin Ther. 2008 ; 30: 482-498
98. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007 ;:
99. Shan HY, Rana S, Epstein FH, Stillman IE, Karumanchi SA, Williams ME. Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis. Am J Kidney Dis. 2008 ; 51: 1029-1032
100. Ruiz-Irastorza G, Khamashta MA. Evaluation of systemic lupus erythematosus activity during pregnancy. Lupus. 2004 ; 13: 679-682
101. Packham D, Fairley KF. Renal biopsy: indications and complications in pregnancy. Br J Obstet Gynaecol. 1987 ; 94: 935-939
102. Soh MC, Hart HH, Bass E, Wilkinson L. Pregnancy complicating Wegener's granulomatosis. Obstet Med. 2009 ; 2: 77-80
103. Klink DT, Van Elbing RM, Schreurs MW, Van Well GT. Rituximab administration in the third trimester of pregnancy suppresses neonatal B-cell development. Clin Develop Immunol. Epub 2008. DOI: 10.1155/2008/271363. Article ID 271363
104. Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynaecol. 1994 ; 101: 488-492
105. Branch DW, Scott JR Phospholipid-binding antibodies. Harris EN Exner T Hughes GRV Asherson R, ed. Boca Raton, FL: CRC Press ; 1991: 853-884.
106. Direskeneli H, Buchanan NM, Khamashta MA, Keser G, D'Cruz D, Hughes GR. Markers of vascular damage in lupus pregnancy. Clin Exp Rheumatol. 1997 ; 15: 535-539
107. Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb Res. 2006 ; 118: 397-407
108. Consensus views arising from the 54th Study Group: Renal disease in pregnancy. Davison JM Nelson-Piercy C Kehoe S Baker P, ed. London: RCOG Press ; 2008: 250-250.
109. Royal College of Obstetricians and Gynaecologists. Reducing the Risk of Thrombosis and Embolism during Pregnancy and the Puerperium Green-top Guideline No. 37. London: RCOG, http://www.rcog.org.uk/womens-health/clinical-guidance/ reducing-risk-of-thrombosis-greentop37a (Accessed online 2009)
110. Bagon JA, Vernaeve H, De Muylder X, Lafontaine JJ, Martens J, Van Roost G. Pregnancy and dialysis. Am J Kidney Dis. 1998 ; 31: 756-765
111. Okundaye I, Abrinko P, Hou S. Registry of pregnancy in dialysis patients. Am J Kidney Dis. 1998 ; 31: 766-773
112. Chan WS, Okun N, Kjellstrand CM. Pregnancy in chronic dialysis: a review and analysis of the literature. Int J Artif Organs. 1998 ; 21: 259-268
113. Beardmore KS, Morris JM, Gallery ED. Excretion of antihypertensive medication into human breast milk: a systematic review. Hypertens Pregnancy. 2002 ; 21: 85-95